DOCSLIB.ORG

The Catalytic Hydrogenation of Benzodiazines

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Catalytic Hydrogenation of Benzodiazines THE CATALYTIC HYDROGENATION OF BENZODIAZINES: I. PHTHALAZINE II. QUINAZOLINE A Dissertation Presented to the Department of Chemistry Brigha~ Young University In Partial Fulfillment of the Requirements for the Degre~ Doctor of Philosophy by Danny Lee Elder August 1969 This dissertation, by Danny Lee Elder, is accepted in its present form b y the Department of Chemistry of Brigham Young University as satisfying the dissertation requirement for the degree of Doctor of Philosophy. ii . , TO Lynette, David, and Douglas iii ACKNOWLEDGEMENTS Deep appreciation is expressed to Dr. H. Smith Broadbent, without whose friendly association, patient help, and kindly ex- · tended advice this research problem could not have been carried out. Gratitude is also expressed £or the many extra-academic endeavors Dr. Broadbent has made on my behalf. Appreciation is extended to the Department of Chemistry of Brigham Young University for financial support in the form of teaching and research assistantships. My wife deserves special thanks for her encouragement, patience, understanding, and especially, for making it all worth- while. Finally, sincere thanks go to a great group of fellow-graduate students--Craig Argyle, Weldon Burnham, Vic Mylroie, Wes Parish, and Walter Sudweeks--for helpful discussions, comrade- ship, and most of all, for the memorable hours spent at such places as Anderson Lake, Four-Lakes Basin, Klondike Bluff, and of course, "Organic Pass, 11 (Grosebeck Pass). iv TABLE OF CONTENTS Chapter Page I. INTRODUCTION • • • • • • • • • • • • • • • 1 II. LITERATURE REVIEW • • • • • • • • • • • • 4 Phthalaz~ne • • • • . 4 Structure and properties • • • • • • • • • · 4 Synthesis of phthalazine • • • • • • • • • 8 Reduced phthalazines • • • • • • • • • • 10 Quinazoline • • • • • • . 12 Structure and properties • . • 12 Synthesis of quinazoline • • • • • 15 Reduced quinazolines • • • • 18 Catalytic Hydrogenation of Benzoazines and Benzodiazines • • • • • • • • 20 Quinoline . 21 . Isoquinoline • • . 22 Quinoxalin e . .. • 23 Cinnoline . 24 Phthalazine • 24 III. EXPERIMENT AL • . • • • • • • 26 ,General Experimental Information •••••. 26 Synthesis of Starting Materials • • • • • • . 30 Phthalazine. • 30 Quinazoline • • . • 35 Preparation of Authentic Samples . 38 V Chapter Page Phthalazine hydrogenation products • • • • 38 Quinazoline hydrogenation products . • • • 46 Hydrogenation of Phthalazine and Quinazoline . • . • . • • • • • 48 General procedures • • • • • .-- 48 Preparation of certain inter .. mediates • • • • • • • • . .. 52 IV. DISCUSSION . 55 Synthesis of Starting Materials • • • • • • • 55 Phthalazine. • • • • • • • • 55 Quinazoline. • • • • • • • • 56 Proposed Hydrogenation Products • • • • • • 57 Proposed phthalazine hydrogenation products • • • • • • • • • • • 58 Proposed quinazoline hydrogenation products • • • • • • • • • • • • • • 59 Identification of Hydrogenation Products 62 Phthalazine hydrogenation products • • • • 62 Quinazoline hydrogenation products • • . • 70 "Minor" quinazoline hydr~genstion products • • • • • • • • • • • • • • 7 2 Quantitative Analysis of Product Mixtures 75 Phthalazine low-pressure hydro .. g enations • • • . • • • • • • • • . • 7 5 Quinazoline low .. pressure hydro-:- g enations • • • . • • • • . • • . 79 Phthalazine high ...pressure hydro- :genations • • . • • • • • • • • • . • 79 Quinazoline high .. pressure hydro ... genations • • • • •. • • • • • • • • • 83 Observations and Conclusions. • • • • • • • 83 vi Chapter Page Relative Activity of Catalysts • • • • • • • • 83 Low-pressure phthalazine hydro .. genations., ••• ., ., •• ., • . .. .. .. .. 85 Low .. pressure quinazoline hydro .. genations • • ,; .; • . .. .. .. .. • • • • • 87 High .. Pressure Reactions . • • • • 87 High .. pressure phthalazine hydro- genations • • • • • • • • •.. • • 88 High-pressure quinazoline hydro .. g enations • • • .; • • .; .; • .; .; 89 Proposed Pathway of Hydrogenations. 90 Phthalazine hydrogenation pathway • • • • 90 Quinazoline hydrogenation pathway. • • • • 96 v. SUMMARY •• . .. .. .. .. .110 VI. LITERATURE CITED . .111 vii LIST OF TABLES Table Page 1. Chromatographic Data • • • • e • • ■ • • I • • 64 2. Low .. Pressure Hydrogenation of Phthalazine • • • • • • • • . 76 3. Low .. Pressure Hydrogenation of Quinazoline • • . • . • • • . 80 4. High--Pressure Hydrogenation of Phthalazin e • • • • • • • • . 81 5. High-Pressure Hydrogenation of Quinazoline . • • . • . • • . 84 6. Hydrogenation of Certain Intermediates 94 viii LIST OF F1GURES Figure Page 1. Proposed Phthalazine Hydrogenation Products . 60 2. Proposed Quinazoline Hydrogenation Products • • • • • • • • • • • • • • • • • • 61 3. Proposed Pathway for Hydrogenation of Phthalazine • • • • • • • • • • • • • • . 91 4. Proposed Pathway for Hydrogenation of Quinazoline • • • • • • • • . • . • • • 97 S. Graph of Molar ,Uptake of Hydrogen with Respect to Time in Low-Press~re Hydrogenations • • • • • • • • • • • • • • • 100 ix LIST OF INFRARED, NUCLEAR MAGNETIC RESONANCE, AND MASS SPECTRA Spectrum .Page Infrared Spectra 1. o<, ~ 1 -Diamino-~-xylene • • • • • • • • • • • • 104 2. £_-Methyl benzylamine . 104 3. 1, 3-Dihydroisoindole • . 104 4. Phthalazine • • • • • • 105 5. 1, 2-Dihydrophthalazine . 105 6. 1, 2, 3, 4-Tetrahydrophthalazine . 105 Nuclear Magnetic Resonance Spectra 7. Phthalazine • • • • • • • • • . 101 8. 1, 2, 3, 4-Tetrahydrophthalazine . 101 9. 1, 2-Dihydrophthalazine . 101 10. o(,cx' -Diamino-~-xylene • • • • • • • • • • • • 102 11. £_-Methylbenzylamine. 102 12. 1, 3-Dihydroisoindole • . 102 13. Quinazoline • • • • . 103 14. 3, 4-Dihydroquinazoline . .. 103 X Spectrum .Page Mass Spectra 15. 1, 2, 3, 4-Tetrahydrophthalazine . .. 106 16. 1, 3-Dihydroisoindole. 106 17. Phthalazine • • • • • • 107 18. 1, 2-Dih ydrophthalazine • . 107 19. (/..~c,:.. 1 -Diamino-;:-xylene . 108 20. £_--Methyl benz ylamine . 109 xi I. INTRODUCTION . Catalytic hydrogenation is one of the most powerful tools available to the synthetic organic chemist. It provides a rela- ti vely simple means of bringing about transformations in organic molecules which might be much more difficult to ' achieve by other chemical methods. A great advantage of catalytic hydro- genation is the convenience with which a reaction can be effected, Many hydrogenation reactions consist of merely agitating catalyst and substrate in a suitable solvent under hydrogen pressure until the theoretical amount of hydrogen has reacted. After filtering the reaction mixture free of catalyst, one can then obtain the desired prodµct by distillation, extraction, or other conventional separation procedure, In many reactions, conditions can be chosen so that high-reaction selectivity-is achieved, giving quantitative yields of the desired product. A great deal of research effort has been expended in improv- ing the technique of catalytic hydrogenation. Many workers have studied the types of transformations which can be brought -about by hydrogenation. Much has been done to develop better 1 2· catalyst systems, and to determine the reaction selectivity of various hydrogenation catalysts. One important area of study has been the catalytic hydrogen .. ation of heterocyclic compounds. Many reports have appeared in the literature concerning the catalytic hydrogenation of hetero-- cycles. However, relatively few of the studies reported have been concerned with the unsubstituted parent-heterocycles, Conspicuously absent from the group of heterocycles which have been studied are the benzodiazines, This group of compounds is comprised of quinoxaline, quinazoline, cinnoline, and phthaiazine, Of these four compounds, quinazoline has received the most at- tention in connection with its catalytic hydrogenation. However, · the variety of catalyst systems and conditions reported is very limited. A systematic study of the catalytic hydrogenation of the ben"". zodiazines was undertaken at Brigham Young University several years ago. Studies of the hydrogenation of quinoxaline and cinno ... line have already been carried out and are reported (23, 98). Ini- tial research on quinazoline has also been carried out (101), but a more complete study is necessary. Phthalazine, the fourth benzodiazine, had not been studied. The catalytic hydrogenation of quinazoline and phthalazine, reported herein, was undertaken with the following objectives in 3 mind: (1) to determine the structure of compounds obtained by hydrogenation of phthalazine and quinazoline, (2) to determine the relative activity of various catalysts in the hydrogenation of phthal .. azine and quinazoline, (3) to elucidate the pathway of hydrogen .. ation for each heterocycle, (4) to determine the synthetic utility of hydrogenation for obtaining the various products formed in the hydrogenation reactions, (5) and to obtain data which would be of value in predicting the course of hydrogenation in other hetero- c ye lie systems. II. LITERATURE REVIEW PHTHALAZINE Structure and Properties Phthalazine or benzo d pyridazine is illustrated below and is num- bered according to the system employed in Chemical Abstracts (72). 8 I :oo~: 5 4 Phthalazine is a white, crystalline substance. It forms white, hard prisms when crystallized from ethyl ether (54). It is very soluble in water, ethanol, benzene, and ethyl acetate; less soluble in ether; and insoluble in ligroin ( 41). When boiled at atmospheric pressure, it gives off ammonia (41, 55), but it is stable when distilled in vacuo. It forms mono-acid salts, Physical data for phthalazine are listed below: Physical Properties 3. 5 (5) 0 mp 90--91
Load more

Recommended publications
  • International Journal of Research in Pharmaceutical Sciences
    Hemalatha K et al., Int. J. Res. Pharm. Sci., 2020, 11(4), 7559-7564 ORIGINAL ARTICLE INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES Published by JK Welfare & Pharmascope Foundation Journal Home Page: www.pharmascope.org/ijrps 4-Anilino Quinazoline Derivatives: Molecular Docking and Evaluation of In vitro Cytotoxic Activity Hemalatha K*1, Sujatha K2, Panneerselvam P3, Girija K1 1Department of Pharmaceutical Chemistry, College of Pharmacy, Mother Theresa Post Graduate and Research Institute of Health Sciences, (A Government of Puducherry Institution), Indira Nagar, Gorimedu, Puducherry-06, India 2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, (Deemed to be University), Porur, Chennai-116, Tamil Nadu, India 3Faculty of Pharmacy,(Medical Campus), Bharath Institute of Higher Education and Research, Chrompet, Chennai-44,Tamil Nadu, India Article History: ABSTRACT Received on: 20 Oct 2020 Revised on: 10 Nov 2020 A novel scaffold of 4-anilino quinazoline derivatives was designed on the basis Accepted on: 23 Nov 2020 of known inhibitor of quinazoline based drugs. The designed derivatives were synthesized using optimized reaction condition. Their structures were con- Keywords: irmed by FT-IR, 1H-NMR, 13C-NMR and Mass spectral data. The structures of synthesized compounds were subjected to in silico molecular docking using Anilino quinazoline, AutoDock software against the target Poly (ADP-ribose) polymerase-1 (PARP- AutoDock software, 1) enzyme. The compounds were evaluated for their in vitro cytotoxic activ- cytotoxic activity, ity against Daltons Lymphocyte Ascites (DLA) Cell lines. Molecular docking PARP 1, study of the newly synthesized compounds showed good binding mode in the Daltons Lymphoma active site of PARP-1.
    [Show full text]
  • Synthesis and Cytotoxicity Evaluation of Some New 4-(4Oxo-4H-Quinazoline-3Yl)- Thiobenzoic Acid-S-(1-H-Benzimidazole-2-Yl) Ester Derivates
    Organic and Medicinal Chemistry International Journal ISSN 2474-7610 Research Article Organic & Medicinal Chem IJ Volume 8 Issue 5 - September 2019 Copyright © All rights are reserved by Farshid Hassanzadeh DOI: 10.19080/OMCIJ.2019.08.555750 Synthesis and Cytotoxicity Evaluation of Some New 4-(4oxo-4H-Quinazoline-3yl)- Thiobenzoic Acid-S-(1-H-Benzimidazole-2-Yl) Ester Derivates Shirin Banitalebi Dehkordi1, Farshid Hassanzadeh1*, Marzieh Rahmani Khajouei2, Hojat Sadeghi1 and Nasim Dana3 1Department of Medicinal Chemistry, Isfahan University of Medical Sciences, Iran 2Isfahan Pharmaceutical Sciences Research Center, Isfahan, Iran 3Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran Submission: August 16, 2019; Published: September 11, 2019 *Corresponding author: Farshid Hassanzadeh, Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, Iran Abstract Quinazolines are a group of heterocyclic compounds that have different biological activities such as cytotoxicity, anti-bacterial, anti-fungal. benzimidazoles on the other hand are also a group of heterocyclic compounds with anti-tumor, anti-virus, anti-fungal and anti-inflammatory effects. Due to significant cytotoxic effects of both quinazoline and benzimidazole derivatives , in this work a group of quinazolinone-benzimidazole hybrids were prepared. The structures of synthesized compounds were confirmed by IR and 1H-NMR. Cytotoxic activity of the compounds was evaluated at 1, 10, and 100 μM concentrations against MCF-7 and HT-29 cell lines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromideKeywords: (MTT) Quinazoline; colorimetric Imidazole; assay. The Cytotoxic results show that compound 9d has highest cytotoxic activity against both MCF-7 and HT-29 cell lines.
    [Show full text]
  • Sodium Chlorite Neutralization
    ® Basic Chemicals Sodium Chlorite Neutralization Introduction that this reaction is exothermic and liberates a If sodium chlorite is spilled or becomes a waste, significant amount of heat (H). it must be disposed of in accordance with local, state, and Federal regulations by a NPDES NaClO2 + 2Na2SO3 2Na2SO4 + NaCl permitted out-fall or in a permitted hazardous 90.45g + 2(126.04g) 2(142.04g) + 58.44g waste treatment, storage, and disposal facility. H = -168 kcal/mole NaClO2 Due to the reactivity of sodium chlorite, neutralization for disposal purposes should be For example, when starting with a 5% NaClO2 avoided whenever possible. Where permitted, solution, the heat generated from this reaction the preferred method for handling sodium could theoretically raise the temperature of the chlorite spills and waste is by dilution, as solution by 81C (146F). Adequate dilution, discussed in the OxyChem Safety Data Sheet thorough mixing and a slow rate of reaction are (SDS) for sodium chlorite in Section 6, important factors in controlling the temperature (Accidental Release Measures). Sodium chlorite increase (T). neutralization procedures must be carried out only by properly trained personnel wearing Procedure appropriate protective equipment. The complete neutralization procedure involves three sequential steps: dilution, chlorite Reaction Considerations reduction, and alkali neutralization. The dilution If a specific situation requires sodium chlorite to step lowers the strength of the sodium chlorite be neutralized, the chlorite must first be reduced solution to 5% or less; the reduction step reacts by a reaction with sodium sulfite. The use of the diluted chlorite solution with sodium sulfite to sodium sulfite is recommended over other produce a sulfate solution, and the neutralization reducing agents such as sodium thiosulfate step reduces the pH of the alkaline sulfate (Na2S2O3), sodium bisulfite (NaHSO3), and solution from approximately 12 to 4-5.
    [Show full text]
  • Catalytic Asymmetric Di Hydroxylation
    Chem. Rev. 1994, 94, 2483-2547 2483 Catalytic Asymmetric Dihydroxylation Hartmuth C. Kolb,t Michael S. VanNieuwenhze,* and K. Barry Sharpless* Department of Chemistry, The Scripps Research Institute, 10666 North Torfey Pines Road, La Jolla, California 92037 Received Ju/y 28, 1994 (Revised Manuscript Received September 14, 1994) Contents 3.1.4. Differentiation of the Hydroxyl Groups by 2524 Selective, Intramolecular Trapping 1. Introduction and General Principles 2483 3.1.5. Miscellaneous Transformations 2525 2. Enantioselective Preparation of Chiral 1,2-Diols 2489 3.2. Preparation of Chiral Building Blocks 2527 from Olefins 3.2.1. Electrophilic Building Blocks 2527 2.1. Preparation of Ligands, Choice of Ligand, 2489 Scope, and Limitations 3.2.2. Chiral Diol and Polyol Building Blocks 2529 2.1.1. Preparation of the Ligands 2490 3.2.3. Chiral Monohydroxy Compounds Derived 2529 from Diols 2.1 -2. Ligand Choice and Enantioselectivity Data 2490 3.2.4. 5- and 6-Membered Heterocycles 2530 2.1.3. Limitations 2491 3.3. Preparation of Chiral Auxiliaries for Other 2530 2.2. Reaction Conditions 2493 Asymmetric Transformations 2.2.1. Asymmetric Dihydroxylation of the 2493 3.3.1. Preparation of 2530 “Standard Substrates” (1 R,2S)-trans-2-phenylcyclohexanol 2.2.2. Asymmetric Dihydroxylation of 2496 3.3.2. Optically Pure Hydrobenzoin (Stilbenediol) 2531 Tetrasubstituted Olefins, Including Enol and Derivatives Ethers 4. Recent Applications: A Case Study 2536 2.2.3. Asymmetric Dihydroxylation of 2496 Electron-Deficient Olefins 5. Conclusion 2538 2.2.4. Chemoselectivity in the AD of Olefins 2497 6. References and Footnotes 2542 Containing Sulfur 2.3.
    [Show full text]
  • Reregistration Eligibility Decision (RED) for Inorganic Sulfites
    Reregistration Eligibility Decision – Inorganic Sulfites May 2007 Reregistration Eligibility Decision Inorganic Sulfites Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental Protection Agency 1801 South Bell Street Arlington, VA 22202 Introduction The Environmental Protection Agency (EPA) has completed its Reregistration Eligibility Decision (RED) for the inorganic sulfites case, which includes the chemicals sulfur dioxide and sodium metabisulfite. This assessment provides information to support the issuance of a Reregistration Eligibility Decision for inorganic sulfites. EPA’s pesticide reregistration process provides for the review of older pesticides (those initially registered prior to November 1984) under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to ensure that they meet current scientific and regulatory standards. In this document, EPA presents the results of its review of the potential human health effects of dietary, drinking water and occupational/bystander exposure to inorganic sulfites, as well as its ecological risk findings. Evaluations performed by the World Health Organization (WHO), the International Agency for Research on Cancer (IARC), and the Agency for Toxic Substances and Disease Registry (ATSDR) were relied upon for this assessment, in addition to peer-reviewed evaluations performed by the Cosmetic Ingredient Review (CIR), the Organization for Economic Cooperation and Development-Screening Information Data Set (OECD-SIDS) and from other open literature sources. Based on this assessment, the Agency has determined that products containing sulfur dioxide or sodium metabisulfite are eligible for reregistration provided the necessary label changes are made. As a result of this assessment, one tolerance has been reassessed. I. Use Information The inorganic sulfites reregistration case includes the chemicals sulfur dioxide (CAS No.
    [Show full text]
  • Review of Litrature
    ejpmr, 2020,7(2), 225-234 SJIF Impact Factor 6.222 EUROPEAN JOURNAL OF PHARMACEUTICAL Review Article Dhanya et al. European Journal of Pharmaceutical and Medical Research AND MEDICAL RESEARCH ISSN 2394-3211 www.ejpmr.com EJPMR CHEMICAL CHARECTERISTICS, SYNTHESIS AND BIOLOGICAL ACTIVITIES OF QUINAZOLINE DERIVATIVES Dhanya S.*1, Prasobh G. R.1, S. M. Sandhya1 and Sebha M. C.1 Sree Krishna College of Pharmacy and Research Centre, Parasala, Thiruvananthapuram, Kerala. *Corresponding Author: Dhanya S. Sree Krishna College of Pharmacy and Research Centre, Parasala, Thiruvananthapuram, Kerala. Article Received on 25/11/2019 Article Revised on 15/12/2019 Article Accepted on 05/01/2020 ABSTRACT Quinazoline is a fused aromatic ring system where a benzene ring is fused to 5th and 6th positions of pyrimidine ring. Quinazolines are medicinally important as anti-convulsant, anti-cancer, anti-microbial, and anti-tubercular properties etc. They target epidermal growth factor receptors on tumour cells. This work is aimed to review the quinazoline derivatives which could deliver drug specifically various receptors and can use as lead in future drug development processes. KEYWORDS: anti-convulsant, anti-cancer, anti-microbial, and anti-tubercular. INTRODUCTION cell growth, differentiation, and survival. EGFR is over Heterocyclic Rings are organic compounds containing at expressed in several human tumors (e.g., breast, ovarian, least one atom of carbon and at least one element other colon, and prostate) and correlates with a poor prognosis than carbon such as sulfur, oxygen or nitrogen within a in many cancer patients. Thus EGFR is an attractive ring structure. These structures may comprise either target for the design and development of compounds that simple aromatic rings or nonaromatic rings.
    [Show full text]
  • A Concise Review on Phthlazine Derivatives and Its Biological Activities
    Aswathy. J et al /J. Pharm. Sci. & Res. Vol. 11(7), 2019, 2526-2532 A Concise Review on Phthlazine Derivatives and its Biological Activities Aswathy. J M.Pharm, Department of Pharmaceutical Chemistry, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom Neyyattinkara, Trivandrum, India-695124 Abstract Phthalazine has good attention in the field of research study due to its wide spectrum of biological activity and therapeutic applications. Phthalazine is a good lead compound for the synthesis of novel drugs. There is a growing interest in the synthesis of several phthalazines derivatives as better drug candidates for the treatment of various diseases. Phthalazine contains a strong pharmacophoric moiety and ring structure it attracts the researchers to this nucleus for the synthesis of novel drugs. Through this review, introduce a new way for a researcher by introducing this nucleus and develop a novel class of drugs who have a better therapeutic profile. In this review, mainly discuss the different pharmacological activity of phthalazine which has already discussed by the researcher. These reports have resulted in a great number of contributions in diverse areas of interest. This study may produce a new way for the researchers to design and develop the phthalazine derivatives with good pharmacological activities. Keywords: Anticancer drug, anticonvulsant activity, antimicrobial agent, phthalazine and tuberculosis. INTRODUCTION activities of phthalazine (figure 1) and phthalazin-1(2H)- Phthalazine is a nitrogen-containing heterocyclic one (figure 2), encouraged us for the designing of new compound. Several research studies are focused on the molecules [1]. phthalazine nucleus due to their wide applicability. Phthalazine derivatives are promising drug candidate for PHARMACOLOGICAL ACTIVITIES OF PHTHALAZINE the treatment of various diseases.
    [Show full text]
  • “Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review)
    AMERICAN ACADEMY OF PEDIATRICS Committee on Drugs “Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review) ABSTRACT. Because of an increasing number of re- bronchospasm from antiasthmatic drugs, aspartame- ports of adverse reactions associated with pharmaceutical induced headache and seizures, saccharin-induced excipients, in 1985 the Committee on Drugs issued a cross-sensitivity reactions in children with sulfon- position statement1 recommending that the Food and amide allergy, benzyl alcohol toxicity in neonates Drug Administration mandate labeling of over-the- receiving high-dose continuous infusion with pre- counter and prescription formulations to include a qual- served medications, dye-related cross-reactions in itative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reac- children with aspirin intolerance, lactose-induced di- tions continue to be reported, although some are no arrhea, and propylene glycol-induced hyperosmola- longer considered clinically significant, and other new lity and lactic acidosis. Although many other excipi- reactions have emerged. The original statement, there- ents have been implicated in causing adverse fore, has been updated and its information expanded. reactions, these are the most significant in the pedi- atric population. ABBREVIATIONS. FDA, Food and Drug Administration; MDIs, metered-dose inhalers ANTIASTHMATIC MEDICATIONS It is readily appreciated that some percentage of asthmatic children will develop a “paradoxical” Pharmaceutical products often contain agents that bronchospasm after they inhale their medication. Be- have a variety of purposes, including improvement cause many of these reactions were attributed to of the appearance, bioavailability, stability, and pal- sulfite, which had been highly publicized as a caus- atability of the product. Excipients (substances ative agent, it was often first suspected.
    [Show full text]
  • QUINAZOLINE DERIVATIVES with POTENT ANTI-INFLAMMATORY and ANTI-ALLERGIC ACTIVITIES A, a B∗∗∗ P
    Int. J. Chem. Sci.: 6(3), 2008, 1119-1146 – A REVIEW QUINAZOLINE DERIVATIVES WITH POTENT ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTIVITIES a, a b∗∗∗ P. MANI CHANDRIKA A. RAGHU RAM RAO , B. NARSAIAH c and M. BHAGAWAN RAJU aMedicinal Chemistry Research Division, University College of Pharmaceutical Sciences, Kakatiya University, WARANGAL – 506 009 (A.P.) India. b Fluoro Organic Division, Indian Institute of Chemical Technology, TARNAKA, Hyderabad (A.P.) INDIA c S. N. Vanita Maha Vidyalaya College, Exhibition Grounds, Nampally, HYDERABAD - 500 007 (A.P.) INDIA. ABSTRACT The biosynthesis modulation of pro-inflammatory cytokines (PICs) has become an important strategy for pharmacological intervention in a variety of inflammatory and fibrotic disease states. Thus , inhibition of PICs will provide the basis f or an effective choice of treatment in inflammatory disorders like rheumatoid arthritis (RA), chronic obstructive pulmonary disease (COPD), asthma, psoriasis , chronic bronchitis and cystic fibrosis. In this review, basic attention is directed towards the s imple and fused substituted quinazolines with proven potencies whose quantitative data are consolidated from literature, which are possessing remarkable anti-inflammatory activity as nitric oxide synthase-II (NOS- II) inhibitors, nuclear factor kappa B (NFKB) inhibitors, tumor necrosis factor-alpha (TNF-α) inhibitors , interleukin-6 (IL-6) inhibitors and combined type 3 and 4 phosphodiesterase (PDE) inhibitors with both bronchodilatory and anti-inflammatory properties. Key words : Inflammation mediators, Substituted quinazolines, Phospho- diesterase inhibitors, Carrageenin–induced paw oedema, Percent inhibition, Adenosine antagonists, Cyclooxygenase inhibitors. INTRODUCTION The aim of this review is to highlight the wide range of developments displayed by ∗ Author for correspondence; E-mail address: [email protected] Fax: +91-40-27160387 1120 P.
    [Show full text]
  • Synthesis and Preliminary In-Vitro Cytotoxic Activity of Morpholino Propoxy Quinazoline Derivatives
    International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.6, No.1, pp 547-555, Jan-March 2014 Synthesis and Preliminary in-vitro Cytotoxic Activity of Morpholino Propoxy Quinazoline Derivatives Bhavesh Prajapati 1*, Ishan Panchal 1 1Sardar Patel College of Pharmacy, Bakrol, Gujarat, India. *Corres.author: [email protected] Phone no: 91-9016156043 Abstract: Present research work is about the synthesis and biological evaluation of morpholino propoxy quinazoline derivatives where in 7-methoxy-6-(3-morpholinopropoxy)3,4-dihydro quinazoline-4-one was converted in to 4-chloro-7-methoxy-6-(3-morphholinopropoxy)quinazoline by treating with Phosphorus oxychloride and N,N-diethyl aniline. 4-chloro-7-methoxy-6-(3-morpholinopropoxy)quinazoline condensed with various substituted aromatic amines and thiol using methanol gives various derivatives of 4-substituted morpholino propoxy quinazoline. Synthesized compounds were tested for their physicochemical properties and were further characterized by spectral analysis using FTIR, NMR and Mass spectroscopy. All synthesized compounds (compound I to VIII) were tested for their cytotoxicity by MTT assay. Among all the synthesized derivatives, compound-II was shown promising anticancer activity as compared to other synthesized derivatives. This was indicated by the IC 50 value of (5.5 and 7.1) respectively for the synthesized derivatives (compound- I and II). And gefitinib shown experimental IC 50 value 4.9µM. Study concluded efficient synthesis of the stated derivatives with the scheme and also prepared derivatives were with promising cytotoxic effect. Keywords: anti-cancer, benzo[d]thiazole, IC 50, 7-methoxy-6-(3-morpholinopropoxy)3,4-dihydroquinazoline-4- one, MTT assay.
    [Show full text]
  • Sulfur Dioxide and Some Sulfites, Bisulfites and Metabisulfites
    SULFUR DIOXIDE AND SOME SULFITES, BISULFITES AND METABISULFITES 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Synonyms and structural and molecular data Sulfr dioxi Chem. Abstr. Serv Reg. No.: 7446-09-5 Replaced CAS Nos.: 8014-94-6; 12396-99-5; 83008-56-4; 89125-89-3 Chem. Abstr. Name; Sulfur dioxide IUPAC Systematic Name: Sulfur dioxide Synonyms: Sulfurous acid anhydride; sulfurous anhydride; sulfurous oxide; sulfur oxide (S02); sulfur superoxide; sulphur dioxide 0=8=0 S02 MoL. wt: 64.07 Sodium sulfte Chem. Abstr. Serv Reg. No.: 7757-83-7 Altemate CAS No.: 10579-83-6 Replaced CAS No.: 68135-69-3 Chem. Abstr. Name: Sulfurous acid, di sodium salt IUPAC Systematic Name: Sulfurous acid, disodium salt Synonyms: Anhydrous sodium sulfite; disodium sulfite; sodium sulphite o 1/ Na · 0 - 8 - 0 · Na Na2S0J MoL. wt: 126.04 Sodium bisulfe Chem. Abstr. Serv Reg. No.: 7631-90-5 Replaced CAS Nos.: 57414-01-4; 69098-86-8; 89830-27-3; 91829-63-9 Chem. Abstr. Name: Sulfurous acid, monosodium salt IUPAC Systematic Name: Sulfurous acid, monosodium salt -131- 132 lARe MONOGRAPHS VOLUME 54 Synonyms: Hydrogen sulfite sodium; monosodium sulfite; sodium acid sulfite; sodium bisulphite; sodium hydrogen sulfite; sodium sulfite (NaHS03) o Il HO - S - a · Na NaHS03 MoL. wt: 104.06 Sodium metabisulfte Chem. Abstr. Serv Reg. No.: 7681-57-4 Altemate CAS No.: 7757-74-6 Replaced CAS No.: 15771-29-6 Chem. Abstr. Name: Disulfurous acid, disodium salt IUPAC Systematic Name: Pyrosulfurous acid, disodium salt Synonyms: Disodium disulfite; disodium metabisulfite; disodium pyrosulfite; sodium disulfite; sodium metabisulphite; sodium pyrosulfite oIl Il0 Na · 0- S - a - S - a · Na .Na2S20S MoL.
    [Show full text]
  • Synthesis and Functionalization of Novel Quinazoline Scaffolds As
    Research & Reviews: Journal of Chemistry e-ISSN:2319-9849 p-ISSN:2322-00 Synthesis and Functionalization of Novel Quinazoline Scaffolds as Antibacterial Agents Shaikha S-Al-Neyadi1, Alaa A Salem1, Akela Ghazawi2, Tibor Pal2 and Ibrahim M Abdou1* 1Department of Chemistry, College of Science, UAE University Al-Ain, 15551 UAE 2Department of Microbiology and Immunology, Faculty of Medicine and Health Sciences, UAE Research Article Received date: 15/08/2018 ABSTRACT Accepted date: 03/08/2018 A new series of Quinazoline derivatives have been designed and Published date: 06/09/2018 synthesized using palladium-catalyzed reactions. The antibacterial activities of the synthesized compounds were screened against four *For Correspondence pathogenic bacteria. Compounds 18b and 9 showed higher sensitivity to S. aureus (gram-positive) with an MIC ≤ 0.25-0.5 μg/ml, respectively. Ibrahim M Abdou, Department of Chemistry, Meanwhile, compounds 13a and 13b were more effective against gram- College of Science, UAE University Al-Ain, negative bacteria, with an MIC<0.25 μg/ml against Escherichia coli, and 15551 UAE, Tel +97137136120. high activities against Pseudomonas aeruginosa, with MIC values of 0.5 and 1.0 μg/ml, respectively. The broadest antibacterial activities were observed with the quinazolines 26a-c, which had MIC value ranging E-mail: [email protected] from<0.25-2 μg/ml. A β-cyclodextrin (β-Cyd) inclusion complex containing quinazolines as a guest was prepared using the kneading method. The Keywords: Quinazoline, Antibacterial synthesis, product was characterized by FTIR and 1H NMR spectrometry, which β-Cyclodextrin, Inclusion complex. proved the formation of the inclusion compound between the host and guest at a molar ratio of 2:1.
    [Show full text]